Efavirenz pharmacokinetics during pregnancy and infant washout
©2019 International Medical Press Background: Limited data exist on efavirenz pharmacokinetics in HIV-positive pregnant women and neonatal washout. Methods: HIV-infected pregnant women receiving 600 mg efavirenz once daily had intensive steady-state 24-h pharmacokinetics profiles during the second t...
Saved in:
Main Authors: | Regis Kreitchmann, Stein Schalkwijk, Brookie Best, Jiajia Wang, Angela Colbers, Alice Stek, David Shapiro, Tim Cressey, Mark Mirochnick, David Burger |
---|---|
Format: | Journal |
Published: |
2019
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85065855757&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/65839 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Efavirenz pharmacokinetics during the third trimester of pregnancy and postpartum
by: Tim R. Cressey, et al.
Published: (2018) -
Raltegravir pharmacokinetics during pregnancy
by: D. Heather Watts, et al.
Published: (2018) -
Raltegravir pharmacokinetics during pregnancy
by: D. Heather Watts, et al.
Published: (2018) -
A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women
by: Stein Schalkwijk, et al.
Published: (2018) -
A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women
by: Stein Schalkwijk, et al.
Published: (2018)